Key result
Elevated preoperative hs-cTnT linked to ~93% higher 1-year mortality after noncardiac surgery.
Why the study?
Few studies explored the association between preoperative high-sensitive cardiac troponin T and long-term mortality after noncardiac surgery.
Cohort (n=7,156)
No
Hazard Ratio: 1.93 (95% CI 1.58–2.36)
Absolute Event Rate: 14.8% vs 3.9%
p-value: p=<0.001
Supports preoperative hs-cTnT for risk stratification in noncardiac surgery; hypothesis-generating and requires prospective trials before practice change.
Background Few studies explored the association between high-sensitive cardiac troponin T (hs-cTnT) and long-term mortality for patients after surgery. This study was conducted to assess the association of hs-cTnT with long-term mortality and to investigate the extent to which this association is mediated via myocardial injury after noncardiac surgery (MINS). Methods This retrospective cohort study included all patients with hs-cTnT measurements who underwent non-cardiac surgery at Sichuan University West China Hospital. Data were collected from February 2018 and November 2020, with follow-up through February 2022. The primary outcome was all-cause mortality within 1 year. As secondary outcomes, MINS, length of hospital stay (LOS), and ICU admission were analyzed. Results The cohort included 7,156 patients (4,299 [60.1%] men; 61.0 [49.0–71.0] years). Among 7,156 patients, there were 2,151 (30.05%) with elevated hs-cTnT(>14 ng/L). After more than 1 year of follow-up, more than 91.8% of mortality information was available. During one-year follow-up after surgery, there were 308 deaths (14.8%) with a preoperative hs-cTnT >14 ng/L, compared with 192 deaths (3.9%) with a preoperative hs-cTnT <=14 ng/L(adjusted hazard ratio [aHR] 1.93, 95% CI 1.58–2.36; p < 0.001). Elevated preoperative hs-cTnT was also associated with several other adverse outcomes (MINS: adjusted odds ratio [aOR] 3.01; 95% CI, 2.46–3.69; p < 0.001; LOS: aOR 1.48, 95%CI 1.34–1.641; p < 0.001; ICU admission: aOR 1.52, 95%CI 1.31–1.76; p < 0.001). MINS explained approximately 33.6% of the variance in mortality due to preoperative hs-cTnT levels. Conclusion Preoperative elevated hs-cTnT concentrations have a significant association with long-term mortality after noncardiac surgery, one-third of which may by accounted for by MINS.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2023) conducted a cohort in Noncardiac surgery (n=7,156). Elevated preoperative high-sensitive cardiac troponin T (hs-cTnT >14 ng/L) vs. Preoperative hs-cTnT ≤14 ng/L was evaluated on All-cause mortality within 1 year (HR 1.93, 95% CI 1.58-2.36, p=<0.001). Elevated preoperative high-sensitive cardiac troponin T (>14 ng/L) was significantly associated with increased 1-year all-cause mortality (HR 1.93) after noncardiac surgery.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: